Elsevier

Hepatology

Volume 22, Issue 2, August 1995, Pages 418-425
Hepatology

Original article
The virological and histological states of anti-hepatitis C virus—positive subjects with normal liver biochemical values

https://doi.org/10.1016/0270-9139(95)90560-XGet rights and content

Abstract

We investigated anti-hepatitis C virus (HCV) titers, HCV RNA levels in liver and serum, genetic variability in the hypervariable region of the genome, the form of the virus in the circulation, and liver histology in 21 anti-HCV-positive subjects with sustained normal liver biochemical values. Titer of anti-HCV was determined by second generation anti-HCV-passive hemagglutination assay, and HCV RNA levels were semiquantitated by reverse transcriptase polymerase chain reaction (PCR). In 19 (90%) of the 21 subjects who had a higher titer of anti-HCV (≥214), HCV RNA was detected in both serum and liver, and histological examination showed minimal or mild chronic hepatitis in all. In the remaining 2 patients who had a lower titer of anti-HCV, HCV RNA was not detected in serum and liver, and liver histology was normal. Anti-HCV titers and HCV RNA levels in serum and liver in the 19 HCV RNA-positive subjects were compared with those levels in the 41 patients with biopsy-proven chronic hepatitis C and elevated serum aminotransferase levels as a control group. There were no significant differences in viral levels in serum and liver between the two groups. To further investigate virological differences between the two groups with regard to degree of genetic variability and the form in the circulation, we performed the PCR-single strand conformation polymorphism (PCR-SSCP) of the hypervariable region 1 and the immunoprecipitation analyses. PCR-SSCP showed that the anti-HCV-positive subjects with normal liver biochemical values had quasispecies nature of the HCV genome similar to the patients with chronic hepatitis C, and the immunoprecipitation analysis showed that the virus circulated both in immune complexes and in the free form in both groups. These findings indicated that both groups had similar virological characteristics but showed different patterns of serum aminotransferase levels and histological findings, suggesting that the two groups may have different immune responses to the virus.

References (23)

  • A Alberti et al.

    Antibody to hepatitis C virus and liver disease in volunteer blood donors

    Ann Intern Med

    (1991)
  • Cited by (110)

    • Epidemiology of Hepatocellular Carcinoma

      2015, Surgical Oncology Clinics of North America
      Citation Excerpt :

      Chronic HCV infection is the leading cause of cirrhosis, and the most common indication for liver transplantation in North and South America, Europe, Australia, and Japan.38,40 Environmental factors such as age greater than 40 years at time of infection,41 degree of alcohol intake (greater than 40–50 g daily), male sex, obesity, presence of an increased alanine transaminase level42,43 and coinfection with HBV or HIV seem to have a greater impact than genotype or viral load in the progression to cirrhosis.39 Unlike other viral infections, antiviral treatment of HCV can eradicate the virus with sustained virologic response (SVR) and the absence of detectable HCV RNA after successful treatment.

    • Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients

      2013, Clinics and Research in Hepatology and Gastroenterology
      Citation Excerpt :

      In our study when we compared patients with normal both aminotransferases (ALT and AST) with the other group of elevated both aminotransferases, we found that there is no statistically significant difference regarding age, sex, and BMI but when separating the aminotransferases, the significant statistical difference appears regarding sex in each AST and ALT separately that is proved by the available literature which suggests that PNALT are characterized by a higher prevalence of female sex only [10,24,25]. No major difference statistically between both groups in serum HCV-RNA titer (genotype 4) that exists in any other HCV genotypes worldwide, although European [21] and Japanese [26] studies show a trend towards a higher relative frequency of genotype (2a, 2b) in patients with normal transferases. This can be explained by the behaviour of chronic infection with HCV genotype 2, which often runs a course of mild necro-inflammation with persistently normal ALT for long periods of time intermingled with ALT flares and a rapid progression of fibrosis [27].

    • Hepatitis B Virus and Hepatitis C Virus: Molecular Biology and Diagnosis

      2006, Perspectives in Medical Virology
      Citation Excerpt :

      Around 25% of chronic HCV carriers may have normal aminotransferase levels (Alberti et al., 1992). These so-called healthy carriers do not differ from the chronic carries with abnormal aminotransferase levels in clinical or virological characteristics (Naito et al., 1994; Jamal et al., 1999), but the histological damage is milder and the progression of the liver lesion is slower than in chronic carriers with elevated aminotransferase levels (Shindo et al., 1995; Mathurin et al., 1998). Recently, a new form of HCV infection called “occult HCV infection” has been described in patients with abnormal liver function tests of unknown etiology (patients were anti-HCV and serum HCV-RNA negative, did not have markers of HBV infection and did not have clinical or biochemical evidences of autoimmunity, genetic or metabolic disorders, alcohol intake or drug toxicity).

    View all citing articles on Scopus
    View full text